Eric Hecht
Directeur Général chez Potomac Pharma, Inc.
Profil
Eric M.
Hecht is currently the Chief Executive Officer at Potomac Pharma, Inc. He previously worked as Chairman at HoustonPharma, Inc., Director at Cambridge Heart, Inc. and GMP Cos., Inc., and President at Ithaka Acquisition Corp.
He also served as a Director at Alsius Corp.
and ALUS Liquidation Corp.
In addition, he worked as a Senior Research Analyst at Morgan Stanley and as an Analyst at Merrill Lynch, Pierce, Fenner & Smith, Inc. Dr. Hecht received his undergraduate degree from Touro College and his doctorate from Yeshiva University.
Postes actifs de Eric Hecht
| Sociétés | Poste | Début |
|---|---|---|
| Potomac Pharma, Inc. | Directeur Général | 01/01/2003 |
Anciens postes connus de Eric Hecht
| Sociétés | Poste | Fin |
|---|---|---|
Alsius Corp. /Old/
 Alsius Corp. /Old/ Medical DistributorsDistribution Services The Group's principal activity is to develops, manufactures, markets and sells, proprietary catheter-based products for rapid cooling and temperature control of patients with severe neuronal injury, including those who have suffered stroke, traumatic brain injury and cardiac arrest. Its products consist of the CoolGard and Thermogard systems and four families of single-use catheters-Cool line, Icy, Fortius and Quattro. The CoolGard and Thermogard systems are computer-controlled temperature regulation systems that circulate cool or warm saline in a closed-loop circuit through balloons that surround their catheters. The Group operating through US, Austria , Germany, France and Rest of Europe. | Directeur/Membre du Conseil | 17/02/2010 |
GMP Cos., Inc.
 GMP Cos., Inc. Pharmaceuticals: MajorHealth Technology GMP Cos., Inc. develops pharmaceuticals, diagnostic products, and medical devices. The firm is also working on treatments for diabetes, glaucoma, and spinal cord injuries. The company was founded in 1999 and is headquartered in Fort Lauderdale, FL | Directeur/Membre du Conseil | 28/12/2009 |
Ithaka Acquisition Corp.
 Ithaka Acquisition Corp. Financial ConglomeratesFinance Ithaka Acquisition Corp. is engaged in providing investment services. The company is located in Miami, FL. | President | 05/10/2006 |
Merrill Lynch, Pierce, Fenner & Smith, Inc. /Old/
 Merrill Lynch, Pierce, Fenner & Smith, Inc. /Old/ Investment Banks/BrokersFinance Merrill Lynch, Pierce, Fenner & Smith, Inc. (MLPFS) is the SEC-registered broker/dealer subsidiary of Merrill Lynch & Co., Inc., ultimately held by Charlotte-based Bank of America Corp. (NYSE: BAC). The firm was founded in 1958 and is headquartered in New York City. In 2010, Banc of America Securities LLC merged with MLPFS and the firm uses the trade name Bank of America Merrill Lynch. MLPFS's global strategy and economics team serves institutional and individual investors using a wide range of macroeconomic disciplines. Their analysis of global issues provides clients with investment ideas, market forecasts, macro overviews and specific sector recommendations across asset classes, regions and disciplines. Their equity research team conducts fundamental analysis on companies globally and provides institutional and retail clients with industry-specific and in-depth research and analysis on numerous industries. The firm's global fixed-income and equity-linked research focuses on fixed-income and equity derivatives, fixed-income strategy, convertibles, commodities, high-yield, mortgages, municipals and global foreign exchange. | Analyst-Equity | 17/11/2000 |
| MORGAN STANLEY | Corporate Officer/Principal | 01/12/1996 |
Formation de Eric Hecht
| Touro College | Undergraduate Degree |
| Yeshiva University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MORGAN STANLEY | Finance |
| Entreprise privées | 8 |
|---|---|
Cambridge Heart, Inc.
 Cambridge Heart, Inc. Medical SpecialtiesHealth Technology Cambridge Heart, Inc. engages in the development and commercialization of products for the non-invasive diagnosis of cardiac disease. The company was founded by Jeffrey M. Arnold and Jordan S. Davis on January 16, 1990 and is headquartered in Tewksbury, MA. | Health Technology |
Merrill Lynch, Pierce, Fenner & Smith, Inc. /Old/
Merrill Lynch, Pierce, Fenner & Smith, Inc. /Old/ Investment Banks/BrokersFinance Merrill Lynch, Pierce, Fenner & Smith, Inc. (MLPFS) is the SEC-registered broker/dealer subsidiary of Merrill Lynch & Co., Inc., ultimately held by Charlotte-based Bank of America Corp. (NYSE: BAC). The firm was founded in 1958 and is headquartered in New York City. In 2010, Banc of America Securities LLC merged with MLPFS and the firm uses the trade name Bank of America Merrill Lynch. MLPFS's global strategy and economics team serves institutional and individual investors using a wide range of macroeconomic disciplines. Their analysis of global issues provides clients with investment ideas, market forecasts, macro overviews and specific sector recommendations across asset classes, regions and disciplines. Their equity research team conducts fundamental analysis on companies globally and provides institutional and retail clients with industry-specific and in-depth research and analysis on numerous industries. The firm's global fixed-income and equity-linked research focuses on fixed-income and equity derivatives, fixed-income strategy, convertibles, commodities, high-yield, mortgages, municipals and global foreign exchange. | Finance |
GMP Cos., Inc.
GMP Cos., Inc. Pharmaceuticals: MajorHealth Technology GMP Cos., Inc. develops pharmaceuticals, diagnostic products, and medical devices. The firm is also working on treatments for diabetes, glaucoma, and spinal cord injuries. The company was founded in 1999 and is headquartered in Fort Lauderdale, FL | Health Technology |
Ithaka Acquisition Corp.
Ithaka Acquisition Corp. Financial ConglomeratesFinance Ithaka Acquisition Corp. is engaged in providing investment services. The company is located in Miami, FL. | Finance |
HoustonPharma, Inc.
 HoustonPharma, Inc. Pharmaceuticals: MajorHealth Technology HoustonPharma, Inc. develops pharmaceutical products and technologies. It develops oncolytic virus technologies for the treatment of cancer, including ovarian cancer, glioblastoma, and multiple myeloma. The company is headquartered in Malvern, PA. | Health Technology |
Alsius Corp. /Old/
Alsius Corp. /Old/ Medical DistributorsDistribution Services The Group's principal activity is to develops, manufactures, markets and sells, proprietary catheter-based products for rapid cooling and temperature control of patients with severe neuronal injury, including those who have suffered stroke, traumatic brain injury and cardiac arrest. Its products consist of the CoolGard and Thermogard systems and four families of single-use catheters-Cool line, Icy, Fortius and Quattro. The CoolGard and Thermogard systems are computer-controlled temperature regulation systems that circulate cool or warm saline in a closed-loop circuit through balloons that surround their catheters. The Group operating through US, Austria , Germany, France and Rest of Europe. | Distribution Services |
| Potomac Pharma, Inc. | |
ALUS Liquidation Corp.
 ALUS Liquidation Corp. Medical SpecialtiesHealth Technology ALUS Liquidation Corp. develops, manufactures, and sells medical products. The company is based in Irvine, CA. | Health Technology |
